Back to Search Start Over

Safety and Efficacy of Switching from Originator to CT-P13 Infliximab Biosimilar in Patients Affected By Spondyloarthritis. a 6-Month Observational Study

Details

Language :
English
Database :
OpenAIRE
Accession number :
edsair.od......3978..356bc564f1f00d105f6e778e12e7f53a